|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00139295 |
|
Date of registration:
|
29/08/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee
|
|
Scientific title:
|
Comparison of the Efficacy and Safety of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee |
|
Date of first enrolment:
|
October 2004 |
|
Target sample size:
|
|
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00139295 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Canada
|
France
|
Germany
|
United Kingdom
|
United States
| | | |
|
Contacts
|
|
Name:
|
Medical Monitor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Genzyme |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Diagnosed with OA of the knee
- Have tried but not been sufficiently helped by conservative treatment, such as weight
reduction and pain medications
Exclusion Criteria:
- Prior or concomitant treatments that would impede measurement of safety and efficacy
Age minimum:
40 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Osteoarthritis, Knee
|
|
Intervention(s)
|
|
Device: Hylastan
|
|
Primary Outcome(s)
|
|
pain relief
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|